ProPhase Labs Inc. has announced the formation of a Clinical Science Advisory Board to support the commercialization of its BE-Smart™ molecular test for esophageal disease, aimed at early detection ...
ProPhase Labs announces BE-Smart's validation for esophageal disease diagnostics, achieving over 95% success in detecting critical biomarkers. ProPhase Labs Inc. announced the successful validation of ...
ProPhase Labs (PRPH) announced that its clinical study by Hartley et al. validating the BE-Smart esophageal cancer test has been accepted for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback